Serum and Ascitic Fluid Superoxide Dismutase and Malondialdehyde Levels in Patients with Cirrhosis. Biomark Insights.

Ozenirler S, Sancak B, Coskun U.

Serum and Ascitic Fluid Superoxide Dismutase and Malondialdehyde Levels in Patients with Cirrhosis. Biomark Insights.

2008 Mar 12;3:141-145. PubMed PMID: 19578501; PubMed Central PMCID: PMC2688367.

İlgili Makaleler

Serum and ascitic fluid nitrate levels in patients with cirrhosis.

21 Ekim 2020

Prognostic importance of tumor angiogenesis in breast carcinoma with adjuvant chemotherapy. 

21 Ekim 2020

A case of Sweet’s syndrome developed after the treatment of herpes simplex infection in a metastatic breast cancer patient.

21 Ekim 2020

Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients.

21 Ekim 2020

Bir yanıt yazın

E-posta adresiniz yayınlanmayacak. Gerekli alanlar * ile işaretlenmişlerdir

Başa dön tuşu
Call Now Button0312 229 20 55